QI Blockchain USD Price & Performance (QIEUSD)

Quest Resource Holding Corporation reported a sharp decline in profitability for Q4 2024, with adjusted EBITDA down to $1.7 million from $3.5 million the previous year. The company is implementing cost-saving measures, including a 15% workforce reduction and debt refinancing, while adding eight new clients and launching operational improvement initiatives.12

Quest Diagnostics' SVP recently sold shares worth $91,138 under a pre-established sales plan. Despite solid Q4 2024 results with revenue and EPS exceeding expectations, the company's 2025 guidance fell slightly short due to higher interest expenses. Quest continues investing in IT and automation to bolster efficiency and customer experience.34

Quest Diagnostics' stock surged 38% over the past year, driven by strong Advanced Diagnostics adoption and strategic acquisitions. The company reported double-digit revenue growth in key areas like molecular diagnostics and Alzheimer's testing. However, high debt levels remain a concern as it focuses on operational excellence and customer expansion.45